At meeting held on 06 August 2015
Mangalam Drugs and Organics announced that the Board of Directors at their Meeting held on 06 August 2015, at a Shorter Notice, interalia transacted the following business:1. Approved the Shorter Notice of Board Meeting.
2. Approved the proposal for fresh issue of upto 26,50,000 Warrants at Rs.65/- each, on preferential basis to J B Pharma LLP, an entity forming part of the promoter group, subject to the approval of the Members, in the upcoming Annual General Meeting to be held on 03 September 2015, and in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations. Each warrant shall be convertible into 1 equity share of Rs.10/- each at a premium of Rs.55/- per equity share within a period of 18 months in one or more tranches from the date of allotment of warrants.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app